[go: up one dir, main page]

NO994612D0 - Retinoid-relaterte molekyler for behandling av ikke-insulinavhengig diabetes mellitus - Google Patents

Retinoid-relaterte molekyler for behandling av ikke-insulinavhengig diabetes mellitus

Info

Publication number
NO994612D0
NO994612D0 NO994612A NO994612A NO994612D0 NO 994612 D0 NO994612 D0 NO 994612D0 NO 994612 A NO994612 A NO 994612A NO 994612 A NO994612 A NO 994612A NO 994612 D0 NO994612 D0 NO 994612D0
Authority
NO
Norway
Prior art keywords
retinoid
insulin
treatment
diabetes mellitus
dependent diabetes
Prior art date
Application number
NO994612A
Other languages
English (en)
Other versions
NO994612L (no
Inventor
Magnus Pfahl
Waldemar Lernhardt
Andrea Fanjol
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of NO994612D0 publication Critical patent/NO994612D0/no
Publication of NO994612L publication Critical patent/NO994612L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Physical Vapour Deposition (AREA)
NO994612A 1997-03-24 1999-09-22 Retinoid-relaterte molekyler for behandling av ikke-insulinavhengig diabetes mellitus NO994612L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3560497P 1997-03-24 1997-03-24
PCT/US1998/005591 WO1998042340A1 (en) 1997-03-24 1998-03-24 Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus

Publications (2)

Publication Number Publication Date
NO994612D0 true NO994612D0 (no) 1999-09-22
NO994612L NO994612L (no) 1999-11-24

Family

ID=21883695

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994612A NO994612L (no) 1997-03-24 1999-09-22 Retinoid-relaterte molekyler for behandling av ikke-insulinavhengig diabetes mellitus

Country Status (11)

Country Link
EP (1) EP1019049A1 (no)
JP (1) JP2001521551A (no)
KR (1) KR20010005678A (no)
CN (1) CN1256630A (no)
AU (1) AU6576398A (no)
BR (1) BR9808054A (no)
CA (1) CA2284192A1 (no)
IL (1) IL132032A0 (no)
NO (1) NO994612L (no)
NZ (1) NZ337927A (no)
WO (1) WO1998042340A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
DE69939485D1 (de) * 1998-11-12 2008-10-16 Smithkline Beecham Plc Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin
AR023699A1 (es) * 1998-11-12 2002-09-04 Smithkline Beecham Corp Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica
US20020198203A1 (en) * 2001-06-07 2002-12-26 Wyeth Combination of a PTPase inhibitor and a thiazolidinedione agent
CN1921843A (zh) * 2004-01-23 2007-02-28 独立行政法人科学技术振兴机构 含视黄酸的糖尿病治疗药
EP3094380B1 (en) * 2014-01-17 2021-04-28 Cornell University Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU647735B2 (en) * 1989-03-08 1994-03-31 University Of Virginia Alumni Patents Foundation, The Dietary supplement for insulin-resistant diabetics
FR2695317B1 (fr) * 1992-09-07 1995-03-10 Monal Lab Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant.
AU676227B2 (en) * 1993-01-22 1997-03-06 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Therapeutic agent for NIDDM
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5444086A (en) * 1994-03-31 1995-08-22 American Home Products Corporation Naphthalenylmethyl thiophenones as antihyperglycemic agents

Also Published As

Publication number Publication date
CN1256630A (zh) 2000-06-14
WO1998042340A1 (en) 1998-10-01
NZ337927A (en) 2000-11-24
IL132032A0 (en) 2001-03-19
NO994612L (no) 1999-11-24
CA2284192A1 (en) 1998-10-01
AU6576398A (en) 1998-10-20
KR20010005678A (ko) 2001-01-15
EP1019049A1 (en) 2000-07-19
JP2001521551A (ja) 2001-11-06
BR9808054A (pt) 2000-11-07

Similar Documents

Publication Publication Date Title
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
DE69817446D1 (de) Behandlung von diabetes
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
FI952721A7 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
FI973255A7 (fi) Karbatsoliyhdisteiden käyttö verentungosta aiheuttavan sydämen toiminnanvajauksen hoidossa
EP1015578A4 (en) THERAPEUTIC MOLECULES
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
DE69714909D1 (de) Piezoelektrisches Element des Dünnschichttyps
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK0769017T3 (da) Terapeutiske forbindelser
ATE292975T1 (de) Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii
FI961213L (fi) Tiatsolidinidionien käyttö insuliinista riippumattoman sokeritaudin syntymisen ehkäisemiseksi tai viivyttämiseksi
FI943108L (fi) Orgaanisia happoja sisältävän jakeen käyttö
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
FI972185L (fi) Aminoguanidiinikarboksylaatit insuliinista riippumaton diabeteksen hoitoon
DE69812708T2 (de) Neue arzneimittel enthaltend uridintriphosphat
NO983770D0 (no) Terapeutisk middel mot diabetes
NO994612D0 (no) Retinoid-relaterte molekyler for behandling av ikke-insulinavhengig diabetes mellitus
DE69800559D1 (de) Ferrielektrische Flüssigkristallverbindung
ID22437A (id) Unit bilah pengaduk
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
NO20012563D0 (no) Anvendelse av benzoylguanidiner til behandling av ikke- insulinavhengig diabetes mellitus
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO943723D0 (no) Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application